Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
https://www.medscape.com/s/viewarticle/992154
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
https://www.thelancet.com/journals/e...502-3/fulltext
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab
https://jamanetwork.com/journals/jam...stract/2804135
https://www.reveal-genomics.com/her2dx